149 related articles for article (PubMed ID: 34386076)
21. Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.
Yun SI; Kwak C; Lee SY; Shin S; Oh C; Kim JS; Rhee HW; Kim KK
FASEB J; 2023 May; 37(5):e22900. PubMed ID: 37039823
[TBL] [Abstract][Full Text] [Related]
22. The Effects of AHCC®, a Standardized Extract of Cultured
Shin MS; Park HJ; Maeda T; Nishioka H; Fujii H; Kang I
J Immunol Res; 2019; 2019():3758576. PubMed ID: 31930148
[TBL] [Abstract][Full Text] [Related]
23. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
[TBL] [Abstract][Full Text] [Related]
24. Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer.
Jing X; Wu H; Ji X; Wu H; Shi M; Zhao R
Oncol Rep; 2016 Oct; 36(4):1946-1952. PubMed ID: 27633051
[TBL] [Abstract][Full Text] [Related]
25. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
[TBL] [Abstract][Full Text] [Related]
26. Generation of cortactin floxed mice and cellular analysis of motility in fibroblasts.
Tanaka S; Kunii M; Harada A; Okabe S
Genesis; 2009 Sep; 47(9):638-46. PubMed ID: 19621352
[TBL] [Abstract][Full Text] [Related]
27. Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells.
Tsunoda K; Oikawa H; Tada H; Tatemichi Y; Muraoka S; Miura S; Shibazaki M; Maeda F; Takahashi K; Akasaka T; Masuda T; Maesawa C
J Invest Dermatol; 2011 Aug; 131(8):1710-9. PubMed ID: 21562571
[TBL] [Abstract][Full Text] [Related]
28. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
29. A Standardized Extract of
Tena-Garitaonaindia M; Ceacero-Heras D; Montoro MDMM; de Medina FS; Martínez-Augustin O; Daddaoua A
Front Microbiol; 2022; 13():814448. PubMed ID: 35369436
[TBL] [Abstract][Full Text] [Related]
30. Combining cortactin and CTTN detection with clinicopathologic features increases effectiveness of survival predictions for patients with resectable hepatocellular carcinoma.
Gang Z; Ya-Lin K; Dong-Qing W; Yu L; Li R; Hong-Yi Z
Clin Lab; 2013; 59(11-12):1343-52. PubMed ID: 24409670
[TBL] [Abstract][Full Text] [Related]
31. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
32. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
33. Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.
Watkins RJ; Imruetaicharoenchoke W; Read ML; Sharma N; Poole VL; Gentilin E; Bansal S; Bosseboeuf E; Fletcher R; Nieto HR; Mallick U; Hackshaw A; Mehanna H; Boelaert K; Smith VE; McCabe CJ
J Clin Endocrinol Metab; 2016 Dec; 101(12):4551-4563. PubMed ID: 27603901
[TBL] [Abstract][Full Text] [Related]
34. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
[TBL] [Abstract][Full Text] [Related]
35. AHCC
Smith JA; Gaikwad AA; Mathew L; Rech B; Faro JP; Lucci JA; Bai Y; Olsen RJ; Byrd TT
Front Oncol; 2022; 12():881902. PubMed ID: 35814366
[TBL] [Abstract][Full Text] [Related]
36. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival.
Folio C; Zalacain M; Zandueta C; Ormazábal C; Sierrasesúmaga L; San Julián M; de las Rivas J; Toledo G; Lecanda F; Patiño-García A
Cancer Biomark; 2011-2012; 10(1):35-41. PubMed ID: 22297550
[TBL] [Abstract][Full Text] [Related]
37. Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC
Pérez-Cantero A; Serrano DR; Navarro-Rodríguez P; Schätzlein AG; Uchegbu IF; Torrado JJ; Capilla J
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31484389
[TBL] [Abstract][Full Text] [Related]
38. Expression of Formin-like 2 and cortactin in gallbladder adenocarcinoma and their clinical significance.
Guo J; Zhang Y; Mao X; Cheng Z; Wu S; Wu S; Zhou L
Int J Clin Exp Pathol; 2020; 13(7):1655-1661. PubMed ID: 32782685
[TBL] [Abstract][Full Text] [Related]
39. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment.
Baron B; Kitagawa T; Nakamura K; Kuramitsu Y
Cancer Genomics Proteomics; 2015; 12(2):49-55. PubMed ID: 25770187
[TBL] [Abstract][Full Text] [Related]
40. The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.
Zhu L; Cho E; Zhao G; Roh MR; Zheng Z
In Vivo; 2019; 33(2):393-400. PubMed ID: 30804117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
